Jefferson Researchers Develop
Genetic Test to Identify Uterine Tumors as Malignant or Benign
Researchers from Thomas Jefferson University have developed a new genetic test that uses reverse transcriptase-polymerase chain reaction (RT-PCR) to identify uterine tumors as malignant or benign.
Mutations in Cornea-Specific
Proteins Discovered as Cause of Fragile Eye Disease
Researchers have discovered genetic mututations that cause Meesmann's corneal dystrophy, a fragile eye disease characterized by a lifelong irritation of the cornea and a weak eye surface vulnerable to injuries and infection that prevents contact lens use.
Placental Leptin a
Possible New Growth Factor in Intrauterine and Newborn
Pediatric researchers from the duPont Hospital for Children, the close affiliate of Thomas Jefferson University, have identified the presence of leptin, a protein linked with obesity, in placental tissues and cells and at elevated levels in the blood of newborns, suggesting that leptin aids in intrauterine and neonatal growth and development.
There have been several recent major developments broadening the geographic reach of Jefferson Health System.
Jeffersonians in the news
News Briefs | Calendar | Staff
Jeffersonians in the News | Past Issues
1996 ANNUAL REPORT
Thomas Jefferson University's 1996 Annual Report is also available through the publications office at 215-955-6204.